Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

NCT01833494 is registered in ClinicalTrials.gov with Kissei Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT01833494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01833494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia
Lead sponsor
Kissei Pharmaceutical Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
March 18, 2013
Completion date
August 4, 2014
Enrollment
161 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis patients with hyperphosphatemia